Gastric Sleeve Surgery

Summary: Sleeve gastrectomy removes roughly 80 percent of the stomach laparoscopically and produces 60 to 70 percent excess weight loss at one to two years, but GLP-1 medications now match or beat those results without surgery for many candidates.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Gastric sleeve surgery is a laparoscopic procedure that permanently removes about 80 percent of the stomach, leaving a narrow banana-shaped tube as the new stomach. It is the most common bariatric operation in the United States, and as of 2026 it is also the procedure most directly threatened by GLP-1 medications, which now produce overlapping weight-loss results without an operation.

This page covers what the surgery actually involves, who qualifies under current ASMBS guidance, what outcomes the data supports at one to two years, the complication profile that matters, what it costs, and how it stacks up against tirzepatide and semaglutide in the current treatment landscape.

What gastric sleeve surgery actually is

The clinical name is laparoscopic vertical sleeve gastrectomy, often abbreviated VSG or LSG. A surgeon makes four to five small incisions in the upper abdomen, inserts a laparoscope and stapling instruments, and uses a calibrating bougie (a flexible tube placed down the esophagus) to size the remaining stomach. About 75 to 85 percent of the stomach, including the fundus that produces most of the body's ghrelin, gets stapled off and removed ^[2][3].

What is left looks like a banana or a narrow sleeve, holding roughly 100 to 150 mL versus the 1500 mL of a normal stomach. The pylorus and the rest of the GI tract stay intact. Food enters, passes through the small new stomach, and continues through the duodenum and small intestine on the same path as before. Nothing is rerouted, which is the key anatomical difference from gastric bypass.

The procedure runs 60 to 90 minutes in most cases. Most patients spend one to two nights in the hospital and are walking the same day ^[3][5].

Who qualifies in 2026

The American Society for Metabolic and Bariatric Surgery updated its indications in 2022 and those guidelines are still in force. The thresholds are now lower than the long-standing 1991 NIH criteria most insurers still reference ^[1].

Current ASMBS indications:

• BMI of 35 or higher, regardless of other conditions. Surgery is recommended.
• BMI of 30 to 34.9 with metabolic disease (type 2 diabetes is the strongest indication). Surgery should be considered.
• BMI of 27.5 or higher in Asian populations, who develop metabolic disease at lower BMIs.
• Adolescents meeting the equivalent criteria, with surgery shown to be safe and effective in this group.

Most US insurers, including Medicare, still anchor on the older 1991 thresholds: BMI 40 or higher, or BMI 35 to 39.9 with at least one obesity-related comorbidity (type 2 diabetes, hypertension, severe sleep apnea, severe GERD, cardiovascular disease). Six months of documented medically supervised weight-loss attempts is a typical insurer requirement, though that rule has loosened in some plans as ASMBS pushed back against it.

The new lower thresholds matter because type 2 diabetes drives the case. A patient with a BMI of 32 and poorly controlled diabetes can now be a surgical candidate per ASMBS, where five years ago they would have been told to lose more weight first.

How long the operation takes and what recovery looks like

Operative time is short. From first incision to last suture, expect 60 to 90 minutes. Total time in the operating room including anesthesia setup runs about two hours ^[3].

The recovery timeline most centers use:

• Hospital stay: one to two nights.
• Week 1: clear liquids only. Sugar-free, noncarbonated. Walking encouraged from day one.
• Weeks 2 to 3: pureed and soft foods. Protein shakes are the calorie backbone.
• Week 4 onward: gradual transition to regular foods in small portions ^[3].
• Return to desk work: typically two to three weeks.
• Return to heavy lifting and full exercise: four to six weeks.

Most patients are eating recognizable meals by week six, just in much smaller portions. Eating slowly and stopping at fullness becomes a permanent behavior change, not a temporary diet.

Expected weight loss outcomes

The number you will see quoted most often is 60 to 70 percent excess weight loss at one year, sustained at one to two years ^[2][5]. Excess weight is the difference between current weight and an ideal weight for height, so a patient 100 pounds over ideal weight loses 60 to 70 of those pounds.

In absolute terms, average total body weight loss runs 25 to 30 percent at the one-year mark. For a 300-pound patient, that is 75 to 90 pounds. Loss peaks around 18 months. Some regain after year two is the norm; the long-term sustained loss at five years is typically 50 to 60 percent of excess weight, with significant variation between patients ^[2].

Beyond the scale, metabolic outcomes are the bigger story. Type 2 diabetes remits or improves in roughly 60 percent of patients within the first year. Hypertension improves in about 70 percent. Obstructive sleep apnea improves or resolves in over 80 percent. These metabolic wins start within weeks, well before most of the weight is gone, which points back to the hormonal mechanism.

Complications and risks

Sleeve gastrectomy has a serious complication rate under 5 percent and a 30-day mortality rate around 0.1 percent, both lower than gastric bypass. The risks are real and worth understanding before you sign consent.

Staple line leak: 0.5 to 2 percent of cases. The staple line where the stomach was divided can leak gastric contents into the abdomen, usually in the first week or two. Symptoms include tachycardia, fever, severe abdominal pain, and elevated white count. A leak is a surgical emergency and the most feared early complication. Diagnosis is by CT with oral contrast, and treatment ranges from endoscopic stenting to reoperation depending on size and timing.

Bleeding: 1 to 2 percent. Usually from the staple line. Most cases resolve without reoperation.

Stricture: 1 to 4 percent. The sleeve can narrow, usually at the incisura angularis, causing food and liquids to back up. Treated with endoscopic balloon dilation; rarely requires conversion to bypass.

GERD: This is the chronic complication that has shifted clinical opinion the most. Sleeve gastrectomy worsens or causes new gastroesophageal reflux in 20 to 30 percent of patients. About 5 percent of patients eventually need conversion to Roux-en-Y gastric bypass primarily because of intractable reflux. Pre-existing severe GERD is a relative contraindication for sleeve and a positive indication for bypass instead.

Hypovitaminosis: Long-term deficiency in B12, iron, vitamin D, calcium, folate, and thiamine. Less severe than after gastric bypass because absorption is preserved, but lifelong daily multivitamin and B12 supplementation is required. Annual labs are standard.

Hair loss: Common between months three and six, usually telogen effluvium from rapid weight loss and protein gaps. Resolves once weight stabilizes and protein intake catches up.

Dumping syndrome: Less common after sleeve than after bypass, but still possible if patients consume concentrated sugars too quickly.

Weight regain: 20 to 30 percent of patients regain a significant portion of lost weight by year five. The sleeve can stretch, hunger can return, and behavioral patterns can re-emerge. This is where GLP-1 medications are increasingly used as adjuncts.

What it costs

Cash-pay pricing in the US runs 15,000 to 25,000 dollars at most accredited centers, with some programs going up to 30,000 dollars for the surgery, anesthesia, hospital stay, and immediate follow-up. The exact bundle varies by hospital, region, and surgeon experience.

With insurance, out-of-pocket cost drops to your deductible plus coinsurance for an inpatient surgery, often 3,000 to 8,000 dollars total. Coverage applies when you meet the plan's BMI and comorbidity criteria and you complete the required pre-surgical workup: a multidisciplinary evaluation, psych clearance, nutritional counseling, and (for most plans) the medically supervised weight-loss trial. Most major insurers, Medicare, and many Medicaid plans cover bariatric surgery for qualifying patients.

Mexico has become a major destination for cash-pay sleeve surgery, with package prices of 4,000 to 6,000 dollars including hotel and transfers. Outcomes at top Tijuana and Cancun centers approach US numbers, but the regulatory environment is different and complications after returning home become your domestic problem. Vet the surgeon's volume, accreditation (look for ISAPS or COE equivalents), and what their re-admission and revision pathways look like before booking.

How sleeve gastrectomy compares to GLP-1 medications

This is the comparison that has reshaped the bariatric field. Five years ago, the question was sleeve versus bypass. Today it is sleeve versus a weekly injection.

The SURMOUNT-1 trial of tirzepatide produced average weight loss of 22.5 percent at the 15 mg dose at 72 weeks. The STEP trials of semaglutide produced about 15 percent. Both are within the range of what sleeve gastrectomy delivers at one to two years ^[4]. A 2024 JAMA analysis comparing GLP-1 outcomes with bariatric surgery confirmed that high-dose tirzepatide approaches sleeve gastrectomy on weight loss alone, though surgery still has the edge on diabetes remission and durability of effect when patients stop treatment ^[4].

For many patients now starting the bariatric workup, the order of operations has flipped. GLP-1 first, surgery only if response is inadequate, intolerance develops, or sustained access becomes impossible. ASMBS has formally acknowledged this shift; surgical volumes have plateaued and in some markets declined since 2023 even as obesity prevalence has not.

The reverse is also true. Patients who have already had sleeve gastrectomy and are experiencing weight regain at year three or beyond are increasingly being prescribed GLP-1 medications as add-on therapy. This combined approach, sleeve plus GLP-1 maintenance, is now common at academic bariatric centers and has its own emerging outcome data.

Sleeve versus gastric bypass

When sleeve is not the right answer, the comparison shifts to Roux-en-Y gastric bypass. Bypass produces slightly more weight loss (about 30 percent total body versus 25 to 30 percent for sleeve), better diabetes remission rates, and treats GERD instead of causing it. The trade-offs are higher complication rates, lifelong malabsorption requiring more aggressive vitamin supplementation, dumping syndrome, and a marginal pleasure of being able to eat normally diminished by the rerouted anatomy.

Sleeve is technically simpler, faster, lower-risk in the short term, and preserves normal GI anatomy. It does not treat severe reflux, does not produce quite the same metabolic benefit, and stretches over time more than bypass does.

The decision usually comes down to: severe GERD or very high BMI with severe diabetes points toward bypass; everything else points toward sleeve.

Is the gastric sleeve safe

By the numbers, yes. Sleeve gastrectomy has lower morbidity and mortality than gallbladder surgery did in the open era and is now safer than hip replacement on a per-procedure basis. Mortality is around 0.1 percent. Serious complication rate is under 5 percent. The MBSAQIP accreditation program (the joint ASMBS/ACS quality program) tracks outcomes at every certified center, and the average results have improved year over year for the last decade.

What "safe" does not mean: free of side effects or long-term consequences. The lifelong vitamin regimen is real. The GERD risk is real. The weight regain potential after year five is real. Safe means the operation itself, in the hands of an experienced surgeon at an accredited center, has a complication profile most patients accept once they understand it.

If you want a quick sanity check on the center you are considering: look for MBSAQIP accreditation, ask the surgeon's annual sleeve volume (over 100 per year is a good signal), and ask for their leak and reoperation rates. A center that cannot answer those questions transparently is the wrong center.

Pros and cons in one table

Common questions about gastric sleeve surgery

How long is gastric sleeve surgery?

The procedure itself takes 60 to 90 minutes. Total operating room time including anesthesia setup is around two hours. Most patients spend one to two nights in the hospital.

How much weight will I lose with the gastric sleeve?

Expect 60 to 70 percent of excess weight at one to two years, or about 25 to 30 percent of total body weight. Peak loss is typically reached around 18 months.

Is the gastric sleeve safe?

Yes, with about a 0.1 percent mortality rate and under 5 percent serious complication rate at accredited centers. It is now safer than many common general surgery procedures.

What is the difference between gastric sleeve and bariatric surgery?

Gastric sleeve is one type of bariatric surgery. Bariatric surgery is the umbrella term covering sleeve, gastric bypass, duodenal switch, and adjustable band procedures. Sleeve is now the most common.

How much does gastric sleeve surgery cost?

15,000 to 25,000 dollars cash in the US. With insurance, typically 3,000 to 8,000 out of pocket if you meet plan criteria. Mexico cash packages run 4,000 to 6,000.

What can you never eat again after gastric sleeve?

There is no permanent forbidden food list, but carbonated drinks, concentrated sugars, and high-fat fried foods often cause discomfort indefinitely. Most patients also eliminate alcohol for at least the first year.

Should I get the sleeve or just take a GLP-1?

For many candidates, a GLP-1 trial first now makes sense. Surgery remains the better choice for patients with very high BMI, those whose insurance does not cover medication long-term, or those who cannot tolerate GLP-1 side effects.

Can I take GLP-1 after gastric sleeve?

Yes. Adding tirzepatide or semaglutide after sleeve, particularly during weight regain at year three or beyond, is now a common combined-care strategy at major bariatric centers.

How long does it take to recover from gastric sleeve surgery?

Most people return to desk work in two to three weeks and to full exercise in four to six weeks. The diet progresses from liquids to pureed to regular foods over the first month.

Does insurance cover gastric sleeve surgery?

Most major insurers, Medicare, and many Medicaid plans cover it for patients meeting BMI and comorbidity criteria, usually with a six-month supervised weight-loss requirement and psych clearance.

What this article does not cover

This is the procedure-level guide. Adjacent topics, including detailed post-op diet phases, specific surgeon and center selection criteria, revision surgery options, and the deeper comparison of sleeve versus bypass for specific patient profiles, have their own dedicated pages on this site. If you are weighing GLP-1 medications as an alternative or supplement to surgery, the tirzepatide and semaglutide guides on the medication side of this site go into the dosing, cost, and access details that the comparison here only summarizes.